FGFR3 GENE MUTATION
Clinical trials for FGFR3 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE MUTATION trials appear
Sign up with your email to follow new studies for FGFR3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug trial aims to control advanced cancers with specific gene fault
Disease control OngoingThis study is testing an investigational drug called TYRA300 for people with advanced bladder cancer and other solid tumors that have specific changes in a gene called FGFR3. The main goals are to find a safe and effective dose and to see if the drug can shrink or control the tum…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Targeted pill tested to shrink recurrent bladder tumors before surgery
Disease control OngoingThis study is testing whether a pill called erdafitinib can shrink recurrent bladder tumors that have a specific genetic change (FGFR3 mutation). The pill is taken by mouth and aims to block a protein that helps the cancer grow. Researchers want to see if giving this pill in the …
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC